Please login to the form below

Not currently logged in
Email:
Password:

emotive boosts its client services team

Agency appoints four new starters

emotive new hires

Healthcare communications agency emotive has strengthened its client services team following new business wins and a ‘successful’ first half of 2017.

Joining as a senior account director, Andy Parry has 9 years’ experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.

Fay Lepley also joins the agency as an account executive and has had experience working in PR and healthcare communications across several therapy areas including cardiovascular, diabetes and HIV.

Additionally, the agency has appointed Oliver Morrissey as its senior account executive following PR and healthcare communications experience in immuno-oncology, CVD and medical devices.

Completing the new team line-up, Sabrina Mohamed has been appointed as account executive after working in healthcare PR, specifically on measurement and social listening in various therapy areas including diabetes and CNS.

Lizzie Nayman, client services director at emotive, said: “We are delighted to welcome Andy, Fay, Oliver and Sabrina to the emotive family, where we have no doubt they will help us continue to provide the very highest levels of service to both our new and existing clients.”

8th August 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics